Skip to content

Harm Reduction Strategies for Gay, Bisexual and Other Men Who Have Sex With Men Engaging in Chemsex

Harm Reduction Strategies for Gay, Bisexual and Other Men Who Have Sex With Men Engaging in Chemsex

Status
Completed
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06187415
Enrollment
25
Registered
2024-01-02
Start date
2024-01-01
Completion date
2025-01-15
Last updated
2026-06-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Harm Reduction

Brief summary

This study is examining the usability and effectiveness of an innovative mobile app that integrates harm reduction strategies into the existing pre-exposure prophylaxis (PrEP) intake and adherence app, with an overarching goal to reduce the potentially negative consequences of problematics chemsex behavior for individuals and communities.

Detailed description

The practice of sexualized drug use is historical and has been noted across a diversity of genders and people of various sexual orientations. The term "chemsex" has been used to specifically describe the use of psychoactive substances in sexualized settings among gay, bisexual, and other men who have sex with men (GBMSM), particularly stimulants like methamphetamine and mephedrone, or other drugs like γ-hydroxybutyrate (GHB), γ-butyrolactone (GBL). Chemsex among GBMSM has coincided with the emergence of sexual-networking mobile apps, creating new opportunities for finding new partners with the intention to engage in chemsex. Harm reduction strategies for GBMSM engaging in chemsex are needed because the use of these drugs can have negative consequences for the physical and mental health of the people who use them. One of the main risks associated with chemsex is the possibility of overdose. In addition to the risk of overdose, chemsex may also increase the risk of sexually transmitted infections (STIs) and HIV transmission due to the higher possibility to engage in risky sexual behaviors. Seeking help can be difficult for GBMSM who engage in chemsex due to stigma, making the harm reduction approach equally important as clinical treatment or intervention that emphasized an abstinence approach. Harm reduction strategies recognize that drug use is a complex issue and that it is not always possible or desirable for people to stop using drugs completely. Instead, harm reduction approaches aim to reduce the harm that can result from drug use and to support people in making healthier choices. Considering also that mobile applications are another way to provide help to hard to reach population, this study aims to develop an innovative mobile app that integrates harm reduction strategies into the existing pre-exposure prophylaxis (PrEP) intake and adherence app. PrEP is a medication that can be taken daily to reduce the risk of HIV transmission. The aim of including PrEP adherence in the self-help harm reduction strategy is to ensure that participants have access to and are using an effective HIV prevention method. Behavior regulation strategies such as providing education about the risks of drug use, overdose prevention and management, and HIV prevention through correct PrEP intake, can be integrated into a mobile app that aims to minimize the negative consequences of drug use and reduce the risks associated with it, with an overarching goal to reduce the potentially negative consequences of problematics chemsex behavior for individuals and communities.

Interventions

BEHAVIORALMobile app to reduce harm of chemsex

Access to the mobile app which includes PrEP diary, demistification of chemsex urban legends, information on the location of needle and syringe services program, and alert sending to emergency contact.

Sponsors

National Cheng Kung University
Lead SponsorOTHER
Healing, Empowerment, Recovery of Chemsex (HERO) integrated care clinic
CollaboratorUNKNOWN

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
SUPPORTIVE_CARE
Masking
NONE

Eligibility

Sex/Gender
MALE
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* individuals need to have a history of drug use (ecstasy, ketamine, crystal methamphetamine, mephedrone, and/or GHB/GBL)in a sexualized context in the previous year * can read and understand chinese, * willing to communicate with the research team through the mobile messenger app Line.

Exclusion criteria

* None

Design outcomes

Primary

MeasureTime frameDescription
Usability of the App1 monthScores on the translated version of the mHealth App Usability questionnaire (MAUQ) was used to assess usability. Responses to the statements on the questionnaire ranged from 1(strongly agree) to 7 (strongly disagree). The questionnaire is the total score of each item divided by the number of items. The closer the mean value is to 1, the higher the app's usability will be.

Countries

Taiwan

Contacts

PRINCIPAL_INVESTIGATORCarol Strong, PhD

National Cheng Kung University

Participant flow

Recruitment details

Participants were recruited from an integrated care clinic specializing in sexual health and chemsex, from current UPrEPU users, and through online channels and word of mouth.

Pre-assignment details

No significant events occurred between enrollment and participation. Eligible participants were directly onboarded to the UPrEPU app and completed baseline assessments. No washout, run-in period, or pre-assignment exclusions were reported.

Baseline characteristics

Characteristic
Age, Customized
Age
≥ 35
13 Participants
Age, Customized
Age
< 35 years
7 Participants
Chemsex services utilization in the past three months
Chemsex care programs affiliated with NGO
4 Participants
Chemsex services utilization in the past three months
Chemsex recovery therapy groups or counseling
9 Participants
Chemsex services utilization in the past three months
Mental health clinic/hospital or rehab center
9 Participants
Chemsex services utilization in the past three months
Needle Syringe Program
2 Participants
Education
Bachelor's degree or higher
16 Participants
Education
lower educational attainment
4 Participants
Employment Status
Employed
18 Participants
Employment Status
Not employed
2 Participants
Preventive behaviors
Doxy-PEP use experience
2 Participants
Preventive behaviors
HIV negative not on PrEP
3 Participants
Preventive behaviors
HIV negative on PrEP
6 Participants
Preventive behaviors
HPV vaccination uptake
13 Participants
Preventive behaviors
Living with HIV
11 Participants
Preventive behaviors
Mpox vaccination uptake
14 Participants
Self-efficacy for sexual safety21.30 Scale scores
STANDARD_DEVIATION 7.73
Sex: Female, Male
Female
0 Participants
Sex: Female, Male
Male
20 Participants
Sexual behaviors
CLAI in past 3 months
19 Participants
Sexual behaviors
Having a sexual partner living with HIV in past 3 months
9 Participants
Sexual behaviors
Numbers of male sexual partners in the past 3 months ≥ 6
6 Participants
Sexual behaviors
Self-reported STI in the lifetime (any kind)
7 Participants
Sexual satisfaction4.48 Scale scores
STANDARD_DEVIATION 1.81
Type of substance used for chemsex
Alkyl nitrites (Rush, poppers)
11 Participants
Type of substance used for chemsex
GHB/GBL
11 Participants
Type of substance used for chemsex
MDMA
4 Participants
Type of substance used for chemsex
Methamphetamine
19 Participants
Type of substance used for chemsex
Sedative
4 Participants
Type of substance used for chemsex
Viagra
14 Participants

Adverse events

Event typeEG000
affected / at risk
deaths
Total, all-cause mortality
0 / 20
other
Total, other adverse events
0 / 20
serious
Total, serious adverse events
0 / 20

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Jun 2, 2026